Zhengxing Huang1, Wei Dong2, Huilong Duan3. 1. College of Biomedical Engineering and Instrument Science, Zhejiang University, China. Electronic address: zhengxinghuang@zju.edu.cn. 2. Department of Cardiology, Chinese PLA General Hospital, China. 3. College of Biomedical Engineering and Instrument Science, Zhejiang University, China.
Abstract
BACKGROUND AND OBJECTIVE: Risk stratification aims to provide physicians with the accurate assessment of a patient's clinical risk such that an individualized prevention or management strategy can be developed and delivered. Existing risk stratification techniques mainly focus on predicting the overall risk of an individual patient in a supervised manner, and, at the cohort level, often offer little insight beyond a flat score-based segmentation from the labeled clinical dataset. To this end, in this paper, we propose a new approach for risk stratification by exploring a large volume of electronic health records (EHRs) in an unsupervised fashion. METHODS: Along this line, this paper proposes a novel probabilistic topic modeling framework called probabilistic risk stratification model (PRSM) based on Latent Dirichlet Allocation (LDA). The proposed PRSM recognizes a patient clinical state as a probabilistic combination of latent sub-profiles, and generates sub-profile-specific risk tiers of patients from their EHRs in a fully unsupervised fashion. The achieved stratification results can be easily recognized as high-, medium- and low-risk, respectively. In addition, we present an extension of PRSM, called weakly supervised PRSM (WS-PRSM) by incorporating minimum prior information into the model, in order to improve the risk stratification accuracy, and to make our models highly portable to risk stratification tasks of various diseases. RESULTS: We verify the effectiveness of the proposed approach on a clinical dataset containing 3463 coronary heart disease (CHD) patient instances. Both PRSM and WS-PRSM were compared with two established supervised risk stratification algorithms, i.e., logistic regression and support vector machine, and showed the effectiveness of our models in risk stratification of CHD in terms of the Area Under the receiver operating characteristic Curve (AUC) analysis. As well, in comparison with PRSM, WS-PRSM has over 2% performance gain, on the experimental dataset, demonstrating that incorporating risk scoring knowledge as prior information can improve the performance in risk stratification. CONCLUSIONS: Experimental results reveal that our models achieve competitive performance in risk stratification in comparison with existing supervised approaches. In addition, the unsupervised nature of our models makes them highly portable to the risk stratification tasks of various diseases. Moreover, patient sub-profiles and sub-profile-specific risk tiers generated by our models are coherent and informative, and provide significant potential to be explored for the further tasks, such as patient cohort analysis. We hypothesize that the proposed framework can readily meet the demand for risk stratification from a large volume of EHRs in an open-ended fashion.
BACKGROUND AND OBJECTIVE: Risk stratification aims to provide physicians with the accurate assessment of a patient's clinical risk such that an individualized prevention or management strategy can be developed and delivered. Existing risk stratification techniques mainly focus on predicting the overall risk of an individual patient in a supervised manner, and, at the cohort level, often offer little insight beyond a flat score-based segmentation from the labeled clinical dataset. To this end, in this paper, we propose a new approach for risk stratification by exploring a large volume of electronic health records (EHRs) in an unsupervised fashion. METHODS: Along this line, this paper proposes a novel probabilistic topic modeling framework called probabilistic risk stratification model (PRSM) based on Latent Dirichlet Allocation (LDA). The proposed PRSM recognizes a patient clinical state as a probabilistic combination of latent sub-profiles, and generates sub-profile-specific risk tiers of patients from their EHRs in a fully unsupervised fashion. The achieved stratification results can be easily recognized as high-, medium- and low-risk, respectively. In addition, we present an extension of PRSM, called weakly supervised PRSM (WS-PRSM) by incorporating minimum prior information into the model, in order to improve the risk stratification accuracy, and to make our models highly portable to risk stratification tasks of various diseases. RESULTS: We verify the effectiveness of the proposed approach on a clinical dataset containing 3463 coronary heart disease (CHD) patient instances. Both PRSM and WS-PRSM were compared with two established supervised risk stratification algorithms, i.e., logistic regression and support vector machine, and showed the effectiveness of our models in risk stratification of CHD in terms of the Area Under the receiver operating characteristic Curve (AUC) analysis. As well, in comparison with PRSM, WS-PRSM has over 2% performance gain, on the experimental dataset, demonstrating that incorporating risk scoring knowledge as prior information can improve the performance in risk stratification. CONCLUSIONS: Experimental results reveal that our models achieve competitive performance in risk stratification in comparison with existing supervised approaches. In addition, the unsupervised nature of our models makes them highly portable to the risk stratification tasks of various diseases. Moreover, patient sub-profiles and sub-profile-specific risk tiers generated by our models are coherent and informative, and provide significant potential to be explored for the further tasks, such as patient cohort analysis. We hypothesize that the proposed framework can readily meet the demand for risk stratification from a large volume of EHRs in an open-ended fashion.
Authors: Juan Zhao; Yun Zhang; David J Schlueter; Patrick Wu; Vern Eric Kerchberger; S Trent Rosenbloom; Quinn S Wells; QiPing Feng; Joshua C Denny; Wei-Qi Wei Journal: J Biomed Inform Date: 2019-08-22 Impact factor: 6.317
Authors: Kirk Roberts; Mary Regina Boland; Lisiane Pruinelli; Jina Dcruz; Andrew Berry; Mattias Georgsson; Rebecca Hazen; Raymond F Sarmiento; Uba Backonja; Kun-Hsing Yu; Yun Jiang; Patricia Flatley Brennan Journal: J Am Med Inform Assoc Date: 2017-04-01 Impact factor: 4.497
Authors: Danqing Hu; Zhengxing Huang; Tak-Ming Chan; Wei Dong; Xudong Lu; Huilong Duan Journal: Int J Environ Res Public Health Date: 2016-09-13 Impact factor: 3.390
Authors: Alison E Fohner; John D Greene; Brian L Lawson; Jonathan H Chen; Patricia Kipnis; Gabriel J Escobar; Vincent X Liu Journal: J Am Med Inform Assoc Date: 2019-12-01 Impact factor: 4.497
Authors: Jonathan H Chen; Mary K Goldstein; Steven M Asch; Lester Mackey; Russ B Altman Journal: J Am Med Inform Assoc Date: 2017-05-01 Impact factor: 4.497